How Could Cheaper Genomic Sequencing Affect the Clinical Testing Industry?
Recently released NGS systems will be helpful to researchers but are unlikely to immediately impact diagnostics, expert says.
Recently released NGS systems will be helpful to researchers but are unlikely to immediately impact diagnostics, expert says.
The inexpensive POC device is a biosensor that performs COMT genotyping as a biomarker for hypnotizability.
Product integration collaborations have become increasingly common, with five such deals being announced between February and mid-March.
While only time will tell how bad the ultimate damage turns out to be, it appears for now at least that the industry has dodged a bullet.
Leanne Davey of Waters Corporation discusses recent technological trends in the clinical space with G2 managing editor Rachel Muenz.